SITE SiteOne: 3 Price Scenarios Ahead of Oct 28 Q3 Release - Thursday Predicted Opening Price? 📈
1 extracted signal · 0 resolved · 1 still active
StockInvest.usIndependent analyst profile- Source published
- 22 Oct 2026, 00:26 UTC
- Recorded by Tahlil Plus
- 22 Oct 2026, 03:21 UTC
AI-generated source summary
The stock exhibits mostly positive short-term signals, including buy signals from both short and long-term Moving Averages, suggesting a favorable short-term forecast. A general buy signal is also present, with the short-term average above the long-term average. Despite an overall falling trend, the current level might offer a buying opportunity. Support levels are identified at $93.87 and $92.14, with a failure below these likely triggering sell signals. A buy signal was issued from a pivot bottom on October 7th, 2026, which has seen a rise of 12.84%. Further upward movement is indicated by a new top pivot. The 3-month Moving Average Convergence Divergence (MACD) also shows a buy signal. Volume declined on the last trading day, which is unusual given the price increase, possibly indicating an early warning. The stock should be closely watched. The price-to-earnings ratio is 26.12, considered normal, and analysts suggest a hold rating with a target of $115.00, while indicating potential risks and medium volatility.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.